Joseph A. Byrne - 31 Dec 2017 Form 5/A - Amendment Insider Report for CEN BIOTECH INC

Role
Chief Executive Officer*, Director
Signature
/s/ Joseph Byrne
Issuer symbol
N/A
Transactions as of
31 Dec 2017
Net transactions value
$0
Form type
5/A - Amendment
Filing time
28 May 2021, 08:30:49 UTC
Date Of Original Report
26 Apr 2021
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CENBF Common Stock Award $0 +20,000 +1.5% $0.000000 1,353,265 30 Nov 2017 Direct F1, F2
transaction CENBF Common Stock Award $0 +1,250,000 +1210% $0.000000 1,353,265 30 Nov 2017 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1,270,000 shares of common stock of the Issuer were granted by the issuer to the reporting person on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
F2 1,353,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.

Remarks:

The reporting person served as the Chief Executive Officer and member of the Board of the Issuer from July 2017 until November 13, 2019, when the reporting person resigned from all positions with the Issuer. The reporting person was appointed as President and a member of the Board of the Issuer effective April 19, 2021.